Clinical data and inflammation parameters in patients with cypress allergy treated with sublingual swallow therapy and subcutaneous immunotherapy

International Journal of Immunopathology and Pharmacology

Volumn 22, Issue 2, 2009, Pages 403-413

  Ventura, M T ^a   Carretta, A ^a   Tummolo, R A ^a   Buquicchio, R ^a   Arsieni, A ^a   Murgia, N ^b  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Cupressaceae; ECP; EOS; Pollens; SCIT; SLIT

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; EOSINOPHIL CHEMOTACTIC FACTOR; JUNIPERUS ASHEI EXTRACT; PLACEBO; PLANT EXTRACT; UNCLASSIFIED DRUG;

ADULT; ALLERGIC CONJUNCTIVITIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG MEGADOSE; EOSINOPHIL; FEMALE; HUMAN; IMMUNOTHERAPY; INFLAMMATION; JUNIPERUS ASHEI; MALE; MEDICINAL PLANT; NOSE MUCUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHINOCONJUNCTIVITIS; SCORING SYSTEM; SENSITIZATION; SUBLINGUAL SWALLOW THERAPY; THERAPY EFFECT; TREATMENT OUTCOME;

EID: 67650445796     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200902200217     Document Type: Article

References (30)

1. Mari A, Di Felice G, Afferni G, Barletta B, Tinghino R, Sallusto F, Pini C. Assessment of skin prick test and serum specific Ige detection in the diagnosis of Cupressaceae pollinosis. J Allergy Clin Immunol 1996; 98:21-31. (Pubitemid 26289382)
2. Ventura MT, Gelardi M, Di Gioia R, Buquicchio R, Accettura G, Tummolo RA, Arsieni A. Statistical evaluation and parameters of phlogosis in patients sensitized to cypress. J Biol Regul Homeost Agents 2007; 21:39-47.
3. Rovira-Seris AC. Analyse des sensibilasations allergiques chez les consultants d'un service de pneumo-allergologie. PhD Thesis 1994; Thèse Marseille 78.
4. Guerra F, Daza JC, Miguel R, Moreno C, Galan C, Dominguez E, Sanchez Guijo P. Sensitivity to Cupressus: allergenic significance in Còrdoba (Spain). J Invest Allergol Clin Immunol 1996; 6:117-120. (Pubitemid 26148458)
5. Charpin D, Calleja M, Lahoz C, Pichot C, Waisel Y. Allergy to cypress pollen. Allergy 2005; 60:293-301.
6. Italian Association of Aerobiology. An epidemiological study of Cupressaceae pollinosis in Italy. J Investig Allergol Clin Immunol 2002; 12:287-292.
7. Mari A, Di Felice G, Afferni G, Barletta B, Tinghino R, Pini C. Cypress allergy: underestimated pollinosis. Allergy 1997; 52:354-355
8. European Academy of Allergology and Clinical Immunology. Position paper of the Subcommittee on Skin tests used in type I allergy testing. Allergy 1989; 44:1-59.
9. Naclerio RM, Proud D, Togias AG. Inflammatory mediators in late antigen-induced rhinitis. New Eng J Med 1985; 313:65-70. (Pubitemid 15068698)
10. Venge P. Serum measurements of eosinophil cationic protein (ECP) in bronchial asthma. Clin Exp Allergy 1993; 23:23-27 (Pubitemid 23195337)
11. Sher R, Glover A. Isolation of human eosinophils and their lymphocyte-like rosetting properties. Immunology 1976; 31:337-341
12. Durham SR, Kay AB. Eosinophils, bronchial hyperreactivity and late phase asthmatic reactions. Clin Allergy 1985; 15:411-418 (Pubitemid 15248000)
13. Snyderman R, Altman LC, Hausman MS, Merghenhasen SE. Human mononuclear leukocyte chemotaxis: a quantitative assay for humoral and cellular chemotactic factor. J Immunol 1972; 108:857-860
14. Hakanson L, Rak S, Dahl R, Venge P. The formation of eosinophil and neutrophil chemotactic activity during pollen season and after allergen challenge. J Allergy Clin Immunol 1989; 83:933-939 (Pubitemid 19147186)
15. Rak S, Hakanson L, Venge P. Immunotheraphy abrogates the generation of eosinophil and neutrophil chemotactic activity during pollen season. J Allergy Clin Immunol 1990; 86:706-713
16. Melzer EO, Orgel HA, Bronsky EA. A dose-ranging study of fluticasone propionate aqueous nasal spray for seasonal allergic rhinitis assessed by symptoms, rhinomanometry and nasal cytology. J Allergy Clin Immunol 1990; 86:221-230 (Pubitemid 20288727)
17. Barletta B, Afferni C, Tinghino R, Mari A, Di Felice G, Pini C. Cross-reactivity between Cupressus arizonica and Cupressus sempervirens pollen extracts. J Allergy Clin Immunol. 1996; 98:797-804. (Pubitemid 26357247)
18. Miller FF, Smith RE, Lawson WJ. Repository emulsion therapy for mountain cedar pollinosis: a double-blind study. J Allergy 1964; 35:7-11.
19. Pence HL, Mitchell DQ, Greely RL, Updegraff BR, Selfridge HA. Immunotherapy for mountain cedar pollinosis. A double-blind controlled study. J Allergy Clin Immunol 1976; 58:39-50.
20. Fling JA, Ruff ME, Parker WA, Whisman BA, Martin ME, Moss RB, Reid MJ. Suppression of the late cutaneous response by immunotherapy. J Allergy Clin Immunol 1989; 83:101-109 (Pubitemid 19052820)
21. Parker W, Whisman B, Apaliski S, Reid MJ. The relationship between late cutaneous responses and specific antibody responses with outcome of immunotherapy for seasonal allergic rhinitis. J Allergy Clin Immunol 1989; 84:667-677 (Pubitemid 20008497)
22. Vervloet D, Birnbaum J, Laurent P, et al. Safety and efficacy of Juniperus ashei sublingual-swallow ultra-rush pollen immunotherapy in cypress rhinoconjunctivitis. Int Arch Allergy Immunol 2007; 142:239-246
23. Charpin D, Gouitaa M, Dron-Gonzalvez M, et al. Immunotherapy with an aluminum hydroxide-adsorbed Juniperus ashei foreign pollen extract in seasonal indigenous cypress pollen rhinoconjunctivitis. Int Arch Allergy Immunol 2007; 143:83-91. (Pubitemid 46742344)
24. Ferreira MB, Santos AS, Santos MC, Carlos ML, Barbosa MA, Carlos AG. Nasal ECP patterns and specific ammunotherapy in mite-allergic rhinitis patients. Allerg Immunol 2005; 37:96-102. (Pubitemid 40515922)
25. Ventura MT, Piccinni T, Matino MG, Giuliano G, Di Corato R, Di Napoli P, Tursi A. Retrospective study on fluticasone propionate aqueous nasal spray efficacy in patients with allergic rhinitis: evaluation of clinical and laboratory parameters. Allergy 2001; 56:29-34. (Pubitemid 32099069)
26. Chen ST, Sun HL, Lu KH, Lue KH, Chou MC. Correlation of immunoglobulin E, eosinophil cationic protein and eosinophil count with the severity of childhood perennial allergic rhinitis. J Microbiol Immunol Infect 2006; 39:212-218 (Pubitemid 44385738)
27. Marcucci F, Sensi L, Frati F, Bernardini R, Novembre E, Barbato A, Pecora S. Effects on inflammation parameters of a double-blind, placebo controlled one-year course of SLIT in children monosensitized to mites. Allergy 2003; 58:657-662 (Pubitemid 36831323)
28. Wang H, Lin X, Hao C, et al. A double-blind, placebo-controlled study of house dust mite immunotherapy in Chinese asthmatic patients. Allergy 2006; 61:191-197 (Pubitemid 43381829)
29. Nagata M, Shibasaki M, Sakamoto Y, Fukuda T, Makino S, Yamamoto K, Dohi Y. Specific immunotherapy reduces the antigen-dependent production of eosinophil chemotactic activity from mononuclear cells in patients with atopic asthma. J Allergy Clin Immunol 1994; 94:160-166 (Pubitemid 24276652)
30. Nagata M, Saito K, Kikuchi I, Tabe K, Hagiwara K, Kanazawa M, Sakamoto Y. Immunotherapy attenuates eosinophil transendothelial migration induced by the supernatants of antigen-stimulated mononuclear cells from atopic asthmatics. Int Arch Allergy Immunol 2004; (S)1:21-24 (Pubitemid 38721122)